A substantial proportion of the drugs (new) under development comprise of high-potency active pharmaceutical ingredients (HPAPIs), which is boosting the demand for increased production. The global high potency APIs market is expected to reach $33.87 Billion by 2025, at a CAGR of 9.49% from $XX Billion in 2019. The primary factors responsible for the growth of the high potency APIs market are growing antibody-drug conjugates, advancements in HPAPI (High Potency API) manufacturing technologies, increasing the focus of leading pharmaceutical companies on HPAPI and growing demand for oncology drugs. However, high risk of cross-contamination, uncertainties associated with products, differences in HPAPI banding and requirement of high investments are significant restraints that are impeding the global high potency APIs market growth.
Research Study Objectives:
- Define, estimate, and forecast the high potency APIs market statistics by type, synthesis type, manufacturer type, therapeutic applications and regions concerning the individual growth drivers, market trends and their contribution toward the high potency APIs market growth
- Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
- Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
- Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the high potency APIs Market analysis
- Analysis and conclusions on the future high potency APIs market outlook.
Top-down and bottom-up approaches are used to validate the high potency APIs market size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary
research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The
high potency APIs market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the
high potency APIs market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.
THE SCOPE OF THE REPORT
The High Potency APIs market segmentation is as follows:
By Type
- Innovative high-potency active pharmaceutical ingredients
- Generic high-potency active pharmaceutical ingredients
By Type of Synthesis
- Synthetic High-Potency Active Pharmaceutical Ingredients
- Synthetic High-Potency Active Pharmaceutical Ingredients Market, By Type
- Innovative Synthetic HPAPI
- Generic Synthetic HPAPI
- Biotech High-Potency Active Pharmaceutical Ingredients
- Biotech High-Potency Active Pharmaceutical Ingredients Market, By Type
- Innovative Biotech HPAPI
- Biosimilars
- Biotech High-Potency Active Pharmaceutical Ingredients Market, By Product
- Monoclonal Antibodies
- Vaccines
- Recombinant Proteins
By Manufacturer Type
- Captive HPAPI Manufacturers
- Merchant HPAPI Manufacturers
- Merchant HPAPI Manufacturers Market, By Type
- Innovative Merchant HPAPI Manufacturers
- Generic Merchant HPAPI Manufacturers
- Merchant HPAPI Manufacturers Market, By Type of Synthesis
- Synthetic HPAPIs
- Biotech HPAPIs
By Therapeutic Application
- Oncology
- Glaucoma
- Hormonal imbalance
- Others
Geographical Analysis:
High Potency APIs Market is segmented by geography into North America, South America, Europe, Asia-Pacific (APAC) and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is
further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.
Customization Options:
With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the high potency APIs Market include:
- Scope Revision
- Geographic Analysis
- Company Profiles
- Historical Data & Forecasting
- Key Contact Persons in companies
Global High Potency APIs Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOTanalysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on year–on–year
- Identifying DROC in the current market and their impact on altering market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the significant high potency APIs market players, such as
- Pfizer Inc.
- Novartis International AG
- Sanofi
- Hoffmann-La Roche AG
- AbbVie Inc.
- Along with these companies, many other companies are considered in the report while analysing the global high potency APIs competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.
